citalopram has been researched along with Hyperprolactinemia in 3 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Risperidone (N=45, 62%) was the most frequently prescribed antipsychotic drug, followed by olanzapine (24, 32%)." | 1.35 | Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting. ( Alacqua, M; Arcoraci, V; Calarese, T; Di Vita, G; Gagliano, C; Germanò, E; Magazù, A; Spina, E; Trifirò, G, 2008) |
| "Hyperprolactinemia is a side effect related to antipsychotics that can cause galactorrhea, gynecomastia, amenorrhea, anovulation, impaired spermatogenesis, decreased libido and sexual arousal, impotence, and anorgasmia, consequent to removal of tonic dopaminergic inhibition of prolactin secretion via hypothalamic dopaminergic receptor blockade in the tuberoinfundibolar tract." | 1.31 | Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. ( Keller, R; Mongini, F, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keller, R | 1 |
| Mongini, F | 1 |
| Alacqua, M | 1 |
| Trifirò, G | 1 |
| Arcoraci, V | 1 |
| Germanò, E | 1 |
| Magazù, A | 1 |
| Calarese, T | 1 |
| Di Vita, G | 1 |
| Gagliano, C | 1 |
| Spina, E | 1 |
| Gulsun, M | 1 |
| Algul, A | 1 |
| Semiz, UB | 1 |
| Ates, MA | 1 |
| Doruk, A | 1 |
| Ebrinc, S | 1 |
| Basoglu, C | 1 |
| Cetin, M | 1 |
3 other studies available for citalopram and Hyperprolactinemia
| Article | Year |
|---|---|
Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
Topics: Adolescent; Adult; Antipsychotic Agents; Citalopram; Dibenzothiazepines; Drug Therapy, Combination; | 2002 |
Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Drug Ut | 2008 |
A case with euprolactinemic galactorrhea induced by escitalopram.
Topics: Adult; Citalopram; Comorbidity; Drug Administration Schedule; Female; Galactorrhea; Humans; Hyperpro | 2007 |